menu
    • menu

    Company profile for MetrioPharm

    NEW Drugs in Dev: 1
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MetrioPharm AG is a pharmaceutical development company focusing on therapies for chronic inflammatory diseases. We are developing a new class of self-regulating drugs against cellular oxidative stress. Oxidative stress is one of the central causes of chronic inflammation, triggering a variety of diseases such as arthritis, dementia, cardiovascular disease and other degenerative age-related indications. MetrioPharm AGs develop...
    MetrioPharm AG is a pharmaceutical development company focusing on therapies for chronic inflammatory diseases. We are developing a new class of self-regulating drugs against cellular oxidative stress. Oxidative stress is one of the central causes of chronic inflammation, triggering a variety of diseases such as arthritis, dementia, cardiovascular disease and other degenerative age-related indications. MetrioPharm AGs development strategy is aimed specifically at these age-related inflammatory conditions. Our lead compound MP1032 is in Phase II clinical development and has demonstrated therapeutic efficacy and an exceptional.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MetrioPharmSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Bleicherweg 10 8002 Zurich
    Telephone
    Telephone
    +41 44 562 03 35
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.metriopharm.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/metriopharm/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS Asia

    IMCAS Asia

    Not Confirmed

    envelop Contact Supplier

    IMCAS Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MetrioPharm Appoints Prof. Jürgen Braun to Advisory Board
    MetrioPharm Appoints Prof. Jürgen Braun to Advisory Board

    26 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-26/metriopharm-ag-prof-dr-med-juergen-braun-appointed-as-new-member-of-the-scientific-advisory-board

    PHARMIWEB
    26 May 2026
    Share Share
    MYR finance chief Christély takes the helm at MetrioPharm
    MYR finance chief Christély takes the helm at MetrioPharm

    20 Aug 2021

    // Kyle LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/ex-myr-finance-chief-joins-covid-19-antiviral-chronic-inflammatory-pharma-metriopharm-as

    Kyle LaHucik FIERCEBIOTECH
    20 Aug 2021
    Share Share
    Thomas Christély Joins Management of MetrioPharm AG as CEO
    Thomas Christély Joins Management of MetrioPharm AG as CEO

    19 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/19/2283318/0/en/Thomas-Christ%C3%A9ly-Joins-Management-of-MetrioPharm-AG-as-CEO.html

    GLOBENEWSWIRE
    19 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search